Хайлтын үр дүнгүүд - Mark Willis

  • 9-н 1 - 9 үр дүнгүүдийг харуулж байна
Үр дүнг сайжруулах
  1. 1
    Alemtuzumab for Multiple Sclerosis

    Alemtuzumab for Multiple Sclerosis -н Mark Willis, Neil P. Robertson

    Хэвлэсэн 2016
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2

    Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2 -н Mark Willis, Neil P. Robertson

    Хэвлэсэн 2020
    Бүрэн текст авах Бүрэн текст авах
    Carta
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Seasonality of Tuberculosis in the United States, 1993-2008

    Seasonality of Tuberculosis in the United States, 1993-2008 -н Mark Willis, Carla A. Winston, Charles M. Heilig, K. P. Cain, Nicholas D. Walter, William R. Mac Kenzie

    Хэвлэсэн 2012
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

    Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis -н Katharine Harding, O. Williams, Mark Willis, James Hrastelj, A.R. Rimmer, Fady Joseph, Valentina Tomassini, Mark Wardle, Trevor Pickersgill, Neil P. Robertson, Emma Tallantyre

    Хэвлэсэн 2019
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    An observational study of alemtuzumab following fingolimod for multiple sclerosis

    An observational study of alemtuzumab following fingolimod for multiple sclerosis -н Mark Willis, Owen Pearson, Zsolt Illés, Tobias Sejbæk, Christian Nielsen, Martin Duddy, Kate Petheram, Caspar E.P. van Munster, Joep Killestein, Clas Malmeström, Emma Tallantyre, Neil P. Robertson

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features

    Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features -н Nadia Pariani, Mark Willis, Ilaria Muller, Sarah Healy, Taha Nasser, Anne McGowan, Greta Lyons, Joanne L. Jones, Krishna Chatterjee, Colin Dayan, Neil P. Robertson, Alasdair Coles, Carla Moran

    Хэвлэсэн 2018
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    <scp>COVID</scp>‐19 Vaccine Response in People with Multiple Sclerosis

    <scp>COVID</scp>‐19 Vaccine Response in People with Multiple Sclerosis -н Emma Tallantyre, Nicola Vickaryous, Valerie Anderson, Aliye Nazli Asardag, David Baker, Jonathan P. Bestwick, Kath Bramhall, Randy Chance, Nikos Evangelou, Katila George, Gavin Giovannoni, Andrew Godkin, Leanne Grant, Katharine Harding, Aimee Hibbert, Gillian Ingram, Meleri Jones, Angray S. Kang, Samantha Loveless, Stuart J. Moat, Neil P. Robertson, Klaus Schmierer, Martin Scurr, Sita Shah, J. Alan Simmons, Matthew Upcott, Mark Willis, Stephen Jolles, Ruth Dobson

    Хэвлэсэн 2021
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

    Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis -н J William L Brown, Alasdair Coles, Dana Horáková, Eva Havrdová, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, María Trojano, Alessandra Lugaresi, Roberto Bergamaschi, Pierre Grammond, Raed Alroughani, Raymond Hupperts, Pamela McCombe, Vincent Van Pesch, Patrizia Sola, Diana Ferraro, François Grand’Maison, Murat Terzi, Jeannette Lechner‐Scott, S Flechter, Mark Slee, Vahid Shaygannejad, Eugenio Pucci, Franco Granella, Vilija Jokubaitis, Mark Willis, Claire M Rice, Neil Scolding, Alastair Wilkins, Owen Pearson, Tjalf Ziemssen, Michael Hutchinson, Katharine Harding, Joanne L. Jones, Christopher McGuigan, Helmut Butzkueven, Tomáš Kalinčík, Neil P. Robertson

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study

    Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study -н Tomáš Kalinčík, J William L Brown, Neil P. Robertson, Mark Willis, Neil Scolding, Claire M Rice, Alastair Wilkins, Owen Pearson, Tjalf Ziemssen, Michael Hutchinson, Christopher McGuigan, Vilija Jokubaitis, Tim Spelman, Dana Horáková, Eva Havrdová, María Trojano, Guillermo Izquierdo, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Raed Alroughani, Eugenio Pucci, Patrizia Sola, Raymond Hupperts, Jeannette Lechner‐Scott, Murat Terzi, Vincent Van Pesch, Csilla Rózsa, François Grand’Maison, Cavit Boz, Franco Granella, Mark Slee, Daniele Spitaleri, Javier Olascoaga, Roberto Bergamaschi, Freek Verheul, Steve Vucic, Pamela McCombe, Suzanne Hodgkinson, José Luis Sánchez-Menoyo, Radek Ampapa, Magdolna Simó, Tünde Csépány, Cristina Ramo‐Tello, Edgardo Cristiano, Michael Barnett, Helmut Butzkueven, Alasdair Coles

    Хэвлэсэн 2017
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: